Πέμπτη 18 Ιανουαρίου 2018

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer, Published online: 18 January 2018; doi:10.1038/bjc.2017.428

Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

http://ift.tt/2Dp9tNh

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου